Lantheus Holdings, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Lantheus Holdings, Inc. (LNTH) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $0 as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2025-02-26
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2024-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.29M.
- 2024-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.80M.
- 2024-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.70M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2024-09-30 | $1.29M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.80M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $2.70M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $2.70M 10-K · filed 2025-02-26 |
| 2023-09-30 | $2.50M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $3.00M 10-Q · filed 2024-07-31 |
| 2023-03-31 | $110.20M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $111.60M 10-K · filed 2025-02-26 |
| 2022-09-30 | $110.50M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $111.50M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $104.20M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $86.20M 10-K · filed 2024-02-22 |
| 2021-09-30 | $46.80M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $43.80M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $17.00M 10-Q · filed 2022-04-29 |
| 2020-12-31 | $15.80M 10-K · filed 2023-02-23 |
| 2020-09-30 | $17.20M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $16.30M 10-Q · filed 2021-07-28 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |